Viewing Study NCT01227902


Ignite Creation Date: 2025-12-25 @ 3:37 AM
Ignite Modification Date: 2026-05-18 @ 7:04 PM
Study NCT ID: NCT01227902
Status: COMPLETED
Last Update Posted: 2014-10-17
First Post: 2010-07-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epilepsy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Seizures View
None retigabine IR View
None GW582892 View
None Epilepsy View
None Open label, flexible dose View
None Partial-onset seizures View